|
|
Volumn 43, Issue 3, 2001, Pages 211-217
|
|
Volume-selective proton MR spectroscopy for in-vitro quantification of anticonvulsants
a
|
|
Author keywords
Anticonvulsant drugs, quantification; Magnetic resonance spectroscopy
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
AROMATIC COMPOUND;
BUFFER;
CARBAMAZEPINE;
DIPOTASSIUM HYDROGEN PHOSPHATE;
PHENOBARBITAL;
PHENYTOIN;
POTASSIUM DIHYDROGEN PHOSPHATE;
SOLVENT;
SULFONIC ACID DERIVATIVE;
TRIMETHYLSILYL DERIVATIVE;
VALPROIC ACID;
WATER;
ARTICLE;
BRAIN TISSUE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DILUTION;
DRUG BLOOD LEVEL;
DRUG BRAIN LEVEL;
DRUG DETERMINATION;
DRUG EFFICACY;
DRUG MONITORING;
DRUG SOLUTION;
DRUG STRUCTURE;
FLUORESCENCE POLARIZATION IMMUNOASSAY;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
MAXIMUM ALLOWABLE CONCENTRATION;
METABOLITE;
NONLINEAR SYSTEM;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
QUANTITATIVE ASSAY;
SEIZURE;
SIGNAL DETECTION;
SPECTRUM;
ANTICONVULSANTS;
HUMANS;
IMMUNOASSAY;
MAGNETIC RESONANCE SPECTROSCOPY;
PROTONS;
REPRODUCIBILITY OF RESULTS;
SEIZURES;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 0035114507
PISSN: 00283940
EISSN: None
Source Type: Journal
DOI: 10.1007/s002340000422 Document Type: Article |
|
Times cited : (11)
|
|
References (16)
|
